Ukraine, the eighth largest European country by population, was often overlooked as a clinical trial site. The country has a large population of modern treatment-naive patients and is far from saturated with clinical trials. The Clinical Trials legislation harmonized with respective EU Directives and Guidelines, educated, qualified and motivated investigators, infrastructure, systems, and capabilities to produce high-quality study results.
CRU-GLOBAL local affiliate is: CRU Ukraine Ltd. in Khust city, established in 2017.
CRU Ukraine is licensed for 26 specialties and conducts Phase I-IV, inpatient and outpatient studies in the following indications: cardiology, diabetology, pulmonology, rheumatology, gastroenterology, gynecology, pediatrics, and oncology.